FortuneDisease Agnostic: Using AI to Pivot and Combat COVID-19Jul 09, 2020Media CoverageRelated contentTempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGsTempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic ApplicationsTempus Reports Second Quarter 2026 Results